Phase 2b Clinical Trial Results Show Aerovance, Inc.'s Aerovant(TM) is Effective in Patients with Eosinophilic Asthma
6/8/2010 10:15:37 AM
More...
|
Aerovance, Inc. Secures $38 Million in Equity Financing
4/7/2009 7:27:06 AM
More...
|
Aerovance, Inc. Initiates Phase IIb Clinical Trial with Aerovant(TM) for the Treatment of Uncontrolled Asthma
3/2/2009 10:20:48 AM
More...
|
Aerovance, Inc. Appoints Babatunde A. Otulana, M.D., as Chief Medical Officer
2/9/2009 10:53:31 AM
More...
|
Data Show Aerovance, Inc.'s Aerovant(TM) Inhalation Powder is Well Tolerated in Asthma Patients
10/7/2008 9:48:59 AM
More...
|
Aerovance, Inc. Secures $20 Million in Debt Financing
3/28/2008 7:45:17 AM
More...
|
Aerovance, Inc. Promotes Anthony Rimac to Vice President, Chief Financial Officer
10/30/2007 8:04:17 AM
More...
|
Aerovance, Inc. Names Mark L. Perry President And CEO
1/4/2007 11:36:46 AM
More...
|
Aerovance, Inc. Announces Positive Top-Line Results from Phase 2a Trial of Inhaled AEROVANT(TM) in Asthma Patients
1/3/2007 2:04:26 PM
More...
|
Aerovance, Inc. Adds Accomplished Product Commercialization Executive To Leadership Team
12/18/2006 11:18:28 AM
More...
|
|